The Severity of Naloxone-Precipitated Opiate Withdrawal Is Attenuated by Felbamate, a Possible Glycine Antagonist

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Neuropsychopharmacology

• Publication date

  1995-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/0893-133X(95)00065-LPMID 8747757
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Kearns-Sayre syndrome

  2013cited by this paper
• Excitatory amino acids and morphine withdrawal: differential effects of central and peripheral kynurenic acid administration

  2005cited by this paper
• Naloxone-precipitated morphine withdrawal increases pontine glutamate levels in the rat.

  1994cited by this paper
• Opiate withdrawal increases glutamate and aspartate efflux in the locus coeruleus: an in vivo microdialysis study.

  1994cited by this paper
• Glutamate antagonists have different effects on spontaneous locomotor activity in rats.

  1994cited by this paper
• Evidence for anticonvulsant and neuroprotectant action of felbamate mediated by strychnine-insensitive glycine receptors.

  1993cited by this paper
• Neuroprotective Effect of Felbamate After Kainic Acid‐Induced Status Epilepticus

  1993cited by this paper
• Destruction of the locus coeruleus decreases physical signs of opiate withdrawal.

  1993cited by this paper
• Efficacy of felbamate in childhood epileptic encephalopathy (Lennox-Gastaut syndrome).

  1993cited by this paper
• The glycine site of the NMDA receptor--five years on.

  1993cited by this paper
• The NMDA antagonist dizocilpine (MK801) attenuates motivational as well as somatic aspects of naloxone precipitated opioid withdrawal.

  1992cited by this paper
• Role of different brain structures in the expression of the physical morphine withdrawal syndrome.

  1992cited by this paper
• Felbamate reduces hypoxic-ischemic brain damage in vivo.

  1992cited by this paper
• D-cycloserine reverses the working memory impairment of hippocampal-lesioned rats in a spatial learning task.

  1992cited by this paper
• Blood‐Brain Barrier Penetration of Felbamate

  1992cited by this paper
• A Neuropharmacological Evaluation of Felbamate as a Novel Anticonvulsant

  1992cited by this paper
• Felbamate monotherapy: Controlled trial in patients with partial onset seizures

  1992cited by this paper
• Felbamate: A Clinical Trial for Complex Partial Seizures

  1991cited by this paper
• Felbamate for partial seizures

  1991cited by this paper
• Actions of D-cycloserine at the N-methyl-D-aspartate-associated glycine receptor site in vivo.

  1991cited by this paper
• Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801.

  1991cited by this paper
• Discontinuation of Phenytoin and Carbamazepine in Patients Receiving Felbamate

  1991cited by this paper
• Glutamate antagonists prevent morphine withdrawal in mice and guinea pigs.

  1991cited by this paper
• Interaction of felbamate and diazepam against maximal electroshock seizures and chemoconvulsants in mice.

  1991cited by this paper
• NMDA receptor antagonists suppress behaviors but not norepinephrine turnover or locus coeruleus unit activity induced by opiate withdrawal.

  1991cited by this paper
• Opiate withdrawal-induced hyperactivity of locus coeruleus neurons is substantially mediated by augmented excitatory amino acid input

  1991cited by this paper
• Glycine is a coagonist at the NMDA receptor/channel complex.

  1990cited by this paper
• Enantiomers of HA-966 (3-amino-1-hydroxypyrrolid-2-one) exhibit distinct central nervous system effects: (+)-HA-966 is a selective glycine/N-methyl-D-aspartate receptor antagonist, but (-)-HA-966 is a potent gamma-butyrolactone-like sedative.

  1990cited by this paper
• Cocaine attenuates the severity of naloxone-precipitated opioid withdrawal.

  1990cited by this paper
• The behavioral pharmacology of NMDA receptor antagonists.

  1990cited by this paper
• D-cycloserine acts as a partial agonist at the glycine modulatory site of the NMDA receptor expressed in Xenopus oocytes.

  1990cited by this paper
• HA-966 antagonizes N-methyl-D-aspartate receptors through a selective interaction with the glycine modulatory site

  1989cited by this paper
• D-cycloserine, a positive modulator of the N-methyl-D-aspartate receptor, enhances performance of learning tasks in rats.

  1989cited by this paper
• HA-966 (1-hydroxy-3-aminopyrrolidone-2) selectively reduces N-methyl-D-aspartate (NMDA)-mediated brain damage.

  1989cited by this paper
• D-cycloserine: a ligand for the N-methyl-D-aspartate coupled glycine receptor has partial agonist characteristics.

  1989cited by this paper
• Withdrawal-induced activation of locus coeruleus neurons in opiate-dependent rats: attenuation by lesions of the nucleus paragigantocellularis.

  1989cited by this paper
• Activation of locus coeruleus from nucleus paragigantocellularis: a new excitatory amino acid pathway in brain

  1988cited by this paper
• Glycine reverses antagonism of N-methyl-D-aspartate (NMDA) by 1-hydroxy-3-aminopyrrolidone-2 (HA-966) but not by D-2-amino-5-phosphonovalerate (D-AP5) on rat cortical slices.

  1988cited by this paper
• Anticonvulsant and antiepileptogenic actions of MK-801 in the kindling and electroshock models.

  1988cited by this paper
• NMDA receptor activation and early olfactory learning.

  1988cited by this paper
• Glycine potentiates the NMDA response in cultured mouse brain neurons

  1987cited by this paper
• Blockade of "NMDA" receptors disrupts experience-dependent plasticity of kitten striate cortex.

  1987cited by this paper
• Ketamine—xylazine anaesthesia blocks consolidation of ocular dominance changes in kitten visual cortex

  1987cited by this paper
• Selective impairment of learning and blockade of long-term potentiation by an N-methyl-D-aspartate receptor antagonist, AP5

  1986cited by this paper
• Comparative Anticonvulsant Activity and Neurotoxicity of Felbamate and Four Prototype Antiepileptic Drugs in Mice and Rats

  1986cited by this paper
• Blockade of N-methyl-D-aspartate receptors may protect against ischemic damage in the brain.

  1984cited by this paper
• Multiple mechanisms of withdrawal from opioid drugs.

  1984cited by this paper
• Long-term potentiation in the hippocampus involves activation of N-methyl-D-aspartate receptors.

  1984cited by this paper
• Excitatory amino acids in synaptic transmission in the Schaffer collateral‐commissural pathway of the rat hippocampus.

  1983cited by this paper
• An iontophoretic investigation of the actions of convulsant kynurenines and their interaction with the endogenous excitant quinolinic acid.

  1982cited by this paper
• Phencyclidine inhibition of the rate of development of amygdaloid kindled seizures.

  1982cited by this paper
• Tolerance of locus coeruleus neurones to morphine and suppression of withdrawal response by clonidine

  1978cited by this paper
• Development of physical dependence on morphine in respect to time and dosage and quantification of the precipitated withdrawal syndrome in rats

  1973cited by this paper

• Gabapentin and D-cycloserine alone and in combination with naloxone in methadone-maintained humans responding under a naloxone novel-response discrimination procedure.

  2025cites this paper
• Rapastinel Accelerates Loss of Withdrawal Signs after Repeated Morphine and Blunts Relapse to Conditioned Place Preference

  2022cites this paper
• Non-Opioid Neurotransmitter Systems that Contribute to the Opioid Withdrawal Syndrome: A Review of Preclinical and Human Evidence

  2019cites this paper
• THE INTERACTION OF LEVETIRACETAM’S ANALGESIA WITH MORPHINE INDUCED TOLERANCE IN TAIL-FLICK MICE MODEL

  2018cites this paper
• Effects of chronic mild stress on the development of drug dependence in rats

  2014cites this paper
• Effects of prototypic calcium channel blockers in methadone-maintained humans responding under a naloxone discrimination procedure.

  2013cites this paper
• Suppressive effects of lamotrigine on the development and expression of tolerance to morphine-induced antinociception in the male mouse.

  2009cites this paper
• Vigabatrin attenuates the development and expression of tolerance to morphine-induced antinociception in mice.

  2009cites this paper
• EFFETS OF ETHOSUXIMIDE ON MORPHINE TOLERANCE AND DEPENDENCE IN MICE

  2007cites this paper
• Review article: The role of anticonvulsant drugs in postoperative pain management: a bench-to-bedside perspective

  2006cites this paper
• Regional Anesthesia And Pain Review article: The role of anticonvulsant drugs in postoperative pain management: a bench-to-bed- side perspective (Le rôle des anticonvulsivants dans le traitement de la douleur postopératoire : perspective d'une application)

  2006cites this paper
• Glutamatergic Mechanisms of Drug Relapse

  2005cites this paper
• Isradipine and dextromethorphan in methadone-maintained humans under a naloxone discrimination procedure.

  2004cites this paper
• Are glycineB sites involved in the development of morphine tolerance?

  2004cites this paper
• Glutamatergic Transmission in Opiate and Alcohol Dependence

  2003cites this paper
• D-cycloserine-Naloxone interactions in opioid-dependent humans under a novel-response naloxone discrimination procedure.

  2003cites this paper
• Lofexidine versus clonidine in rapid opiate detoxification.

  2001cites this paper
• Glutamate Receptors and Nociception

  2001cites this paper
• Attenuation of morphine dependence and withdrawal by glycine B site antagonists in rats.

  2001cites this paper
• The effect of the glycine/NMDA receptor antagonist, (+)-HA966, on morphine dependence in neuropathic rats.

  2000cites this paper
• Rapid opiate detoxication in outpatient treatment: relationship with naltrexone compliance.

  2000cites this paper
• Neurobiological Adaptations to Psychostimulants and Opiates as a Basis of Treatment Development

  2000cites this paper
• Short-acting NMDA receptor antagonist MRZ 2/576 produces prolonged suppression of morphine withdrawal in mice

  2000cites this paper
• Common Mechanisms Underlying Opioid Tolerance and Dependence and Neuropathic Pain: Role of Metabotropic Glutamate Receptors

  2000cites this paper
• N-Methyl-D-aspartate receptor antagonists and the development of tolerance to the discriminative stimulus effects of morphine in rats.

  1999cites this paper
• Glycine and N-methyl-D-aspartate receptors: physiological significance and possible therapeutic applications.

  1998cites this paper
• beta-Phenylethylamines and the isoquinoline alkaloids.

  1997cites this paper
• Endogenous opiates: 1995.

  1996cites this paper
• The Effects of NMDA Receptor Antagonists and Nitric Oxide Synthase Inhibitors on Opioid Tolerance and Withdrawal

  1995cites this paper